clinical trial · NCT07020832
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Delayed Graft FunctionEnd Stage Renal DiseaseDeceased Donor Kidney TransplantPegcetacoplanPlacebo
brief summary
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
started
Feb 1, 2026
primary completion
Aug 1, 2027
completion
Aug 1, 2028
last updated
Mar 13, 2026
official title
A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol